| Cancer incidence after retinoblastoma: radiation dose and sarcoma risk FL Wong, JD Boice, DH Abramson, RE Tarone, RA Kleinerman, M Stovall, ... Jama 278 (15), 1262-1267, 1997 | 856 | 1997 |
| Germline mutations in BAP1 predispose to melanocytic tumors T Wiesner, AC Obenauf, R Murali, I Fried, KG Griewank, P Ulz, ... Nature genetics 43 (10), 1018-1021, 2011 | 799 | 2011 |
| Mortality from second tumors among long-term survivors of retinoblastoma C Eng, FP Li, DH Abramson, RM Ellsworth, FL Wong, MB Goldman, ... JNCI: Journal of the National Cancer Institute 85 (14), 1121-1128, 1993 | 730 | 1993 |
| Retinoblastoma H Dimaras, TW Corson, D Cobrinik, A White, J Zhao, FL Munier, ... Nature reviews Disease primers 1 (1), 1-23, 2015 | 603 | 2015 |
| A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma: initial results DH Abramson, IJ Dunkel, SE Brodie, JW Kim, YP Gobin Ophthalmology 115 (8), 1398-1404. e1, 2008 | 593 | 2008 |
| Second nonocular tumors in retinoblastoma survivors: are they radiation-induced? DH Abramson, RM Ellsworth, FD Kitchin, G Tung Ophthalmology 91 (11), 1351-1355, 1984 | 587 | 1984 |
| Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up RA Kleinerman, MA Tucker, RE Tarone, DH Abramson, JM Seddon, ... Journal of Clinical Oncology 23 (10), 2272-2279, 2005 | 581 | 2005 |
| Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience YP Gobin, IJ Dunkel, BP Marr, SE Brodie, DH Abramson Archives of ophthalmology 129 (6), 732-737, 2011 | 520 | 2011 |
| Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial RD Carvajal, JA Sosman, JF Quevedo, MM Milhem, AM Joshua, ... Jama 311 (23), 2397-2405, 2014 | 474 | 2014 |
| Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk DH Abramson, CM Frank Ophthalmology 105 (4), 573-580, 1998 | 413 | 1998 |
| Variates of survival in metastatic uveal melanoma P Rietschel, KS Panageas, C Hanlon, A Patel, DH Abramson, ... Journal of Clinical Oncology 23 (31), 8076-8080, 2005 | 380 | 2005 |
| Presenting signs of retinoblastoma DH Abramson, CM Frank, M Susman, MP Whalen, IJ Dunkel, NW Boyd III The Journal of pediatrics 132 (3), 505-508, 1998 | 378 | 1998 |
| Update on retinoblastoma DH Abramson, AC Schefler Retina 24 (6), 828-848, 2004 | 340 | 2004 |
| Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival DH Abramson, K Beaverson, P Sangani, RA Vora, TC Lee, HM Hochberg, ... Pediatrics 112 (6), 1248-1255, 2003 | 288 | 2003 |
| Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16. BM Melia, DH Abramson, DM Albert, HC Boldt, JD Earle, WF Hanson, ... Ophthalmology 108 (2), 348-366, 2001 | 286 | 2001 |
| Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? BL Gallie, RM Ellsworth, DH Abramson, RA Phillips British journal of cancer 45 (4), 513-521, 1982 | 286 | 1982 |
| Nonocular cancer in retinoblastoma survivors. DH Abramson, RM Ellsworth, LE Zimmerman Transactions. Section on Ophthalmology. American Academy of Ophthalmology …, 1976 | 273 | 1976 |
| Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma RA Kleinerman, MA Tucker, DH Abramson, JM Seddon, RE Tarone, ... Journal of the National Cancer Institute 99 (1), 24-31, 2007 | 272 | 2007 |
| Treatment of retinoblastoma in 2015: agreement and disagreement DH Abramson, CL Shields, FL Munier, GL Chantada JAMA ophthalmology 133 (11), 1341-1347, 2015 | 269 | 2015 |
| Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling XL Xu, Y Fang, TC Lee, D Forrest, C Gregory-Evans, D Almeida, A Liu, ... Cell 137 (6), 1018-1031, 2009 | 255 | 2009 |
